35 results on '"Meunier, Lucy"'
Search Results
2. SAT-306 Time to use the right classification to predict the severity of checkpoint inhibitor-induced liver injury
3. OS-097 Effect of rifaximin in severe cirrhotic patients with ascites: a double-blind randomized placebo-controlled phase 3 trial
4. SAT-331 Anticancer drugs are the first cause of drug-induced liver injury in the REFHEPS network
5. CDK4/6 inhibitors-induced liver injury: Clinical phenotypes and role of the corticosteroid treatment
6. irLI or Not irLI: That is the Question
7. Cholangitis Induced by Immune Checkpoint Inhibitors: Analysis of Pharmacovigilance Data
8. Combination immune checkpoint therapy carried on despite grade 4 immune-related hepatotoxicity during treatment of metastatic melanoma: Case report and review of literature
9. Integrating an addiction team into the management of patients transplanted for alcohol-associated liver disease reduces the risk of severe relapse
10. Acute liver failure following immune checkpoint inhibitors
11. CDK 4/6 inhibitors induced liver injury: 7 cases from REFHEPS registry
12. Clinical pattern of checkpoint inhibitor-induced liver injury in a multicentre cohort
13. Hemoglobin is a short-term prognostic factor in decompensated alcohol-associated cirrhosis: a multicenter prospective study
14. Immune checkpoint inhibitors induced liver injury: an observational study
15. Efficacy and safety of SARS-CoV-2 vaccination in liver transplant recipients
16. Fibroblast Growth Factor 19 stimulates water intake
17. Can azathioprine prevent infliximab-induced liver injury?
18. Acute liver failure secondary to Langerhans cell histiocytosis
19. Liver transplantation for patients with acute-on-chronic liver failure (ACLF) in Europe: Results of the ELITA/EF-CLIF collaborative study (ECLIS)
20. Hydrochlorothiazide-induced hepatotoxicity: A rare case of DILI
21. Covid-19 in liver transplant recipients: the French SOT COVID registry
22. Liver transplantation for patients with acute-on-chronic liver failure (ACLF) in Europe: results of the ELITA/EF-CLIF collaborative study (ECLIS)
23. Hepatic amyloidosis as a case of fatal fulminant liver failure
24. Chemotherapy-associated steatohepatitis
25. HCV treatment in cirrhotic patients: Should we use a different approach for patients awaiting a liver transplant
26. Drug induced liver injury and vascular liver disease
27. Prospective study of therapeutic education (TE) designed with a multidisciplinary team and participation of patients to improve the adherence to treatment of the patients and their quality of life (QOL)
28. Acute liver failure requiring transplantation caused by ulipristal acetate
29. Exploring predicted indirectly recognizable HLA epitopes (PIRCHE-II) in liver transplant recipients on calcineurin inhibitor-free maintenance immunosuppression. A retrospective single center study
30. Potential role of ketamine in burn-associated cholestasis
31. FRI-088-The good use of non steroidal anti-inflammatory drugs (nsaids): prospective assessment of the knowledge of prescribers (practitioners, residents), care providers (nurses), pharmacists and students in an university medical center
32. SAT-248-Patients treated for HCV and listed for LT in a French multicenter study: What happens at 3 years?
33. FRI-087-The good use of paracetamol: prospective assessment of the knowledge of prescribers ( practitioners, residents), pharmacists, care providers (nurses, others) and students in an university medical center
34. Recent Advances in Hepatotoxicity of Non Steroidal Anti-inflammatory Drugs
35. Liver Biopsy in Chronic Liver Diseases: Is There a Favorable Benefit: Risk Balance?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.